Efficacy of avelumab maintenance therapy for advanced urothelial carcinoma with histologic subtype and divergent differentiation: a multicenter retrospective study conducted by the Uro-Oncology Group in Kyushu.
Akinori MinatoNobuki FurubayashiToshihisa TomodaYoshifumi HoriKeijiro KiyoshimaTakahito NegishiKentaro KuroiwaIkko TomisakiKenichi HaradaMotonobu NakamuraNaohiro FujimotoPublished in: Translational andrology and urology (2024)
The response of SUC and PUC to avelumab was comparable in patients with advanced lower and upper urinary tract cancer, indicating that avelumab maintenance therapy is also effective for SUC.